Enspryng (satralizumab)

pCPA File Number: 21451
Negotiation Status:
Concluded with an LOI
Indication(s):
Neuromyelitis optica spectrum disorder (NMOSD)
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
SR0663-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: